Rac1 regulates protrusion and invasion of breast cancers in 3D

Rac1 以 3D 方式调节乳腺癌的突出和侵袭

基本信息

项目摘要

DESCRIPTION (provided by applicant): In invasive breast adenocarcinomas, the mechanism by which the invading cells crawl through the matrix involves two distinct processes that must be well coordinated to affect an efficient invasion. The matrix degrading protrusions (invadopodia) must be able to efficiently degrade the matrix, retract, and allow for the protrusion of the locomotory pseudopodia/lamellipodia into the degraded hole in the matrix, and this process must cycle to achieve a continuous invasive migration. The molecular basis underlying the assembly process of invadopodia is well documented, involving the p21 Rho family of small GTPases including Cdc42, RhoA and RhoC; however how the invadopodia disassembles upon completion of the matrix degradation and how the phenotype switches from that of matrix degradation to bulk locomotive protrusion is not yet clear. Here, we propose that the p21 Rho family GTPase member Rac1 GTPase is critically involved in the disassembly of invadopodia in invasive breast adenocarcinomas, and at the same time drives the protrusion of the pseudopodia/lamellipodia in 2- and 3-dimensions. Furthermore, we hypothesize that Rac1 activates two distinct and separate downstream pathways through interacting with two different downstream effector targets, responsible for affecting each of the processes separately. We further hypothesize that the observations we make regarding the role of Rac1 in invadopodia versus the leading edge lamellipodia in 2 dimensional culture conditions can be extended to 3 dimensional invasion where the matrix degrading and the bulk locomotive protrusion compartments converge into the same space. We will approach this problem using our new genetically encoded biosensor for Rac1 GTPase, capable of reporting the activation dynamics of Rac1 in real time at subcellular resolutions, and we will utilize the state-of-the-art photouncaging technologies for Rac1 GTPase to further address the role of Rac1 activation at invadopodia. This study will provide the first evidence into how the activation cycling of a singl GTPase Rac1, can efficiently switch the phenotype of invasive/motility machinery from matrix degradation to bulk locomotory protrusion in 2D and in 3D invasion settings.
描述(由申请人提供):在浸润性乳腺腺癌中,侵袭细胞通过基质爬行的机制涉及两个不同的过程,必须很好地协调以影响有效的侵袭。 基质降解突起(侵入伪足)必须能够有效地降解基质,缩回,并允许运动伪足/板状伪足突出到基质中的降解孔中,并且该过程必须循环以实现连续的侵入性迁移。 侵入伪足组装过程的分子基础已得到充分证明,涉及小GTP酶的p21 Rho家族,包括Cdc 42、RhoA和RhoC;然而,在基质降解完成后,侵入伪足如何分解以及表型如何从基质降解转变为大块运动突起尚不清楚。 在这里,我们提出p21 Rho家族GTPase成员Rac 1 GTPase在侵袭性乳腺腺癌中侵袭伪足的分解中发挥着关键作用,同时驱动伪足/板状伪足的二维和三维突出。 此外,我们假设Rac 1通过与两个不同的下游效应靶点相互作用激活两个不同且独立的下游途径,分别负责影响每个过程。 我们进一步假设,我们在二维培养条件下对Rac 1在侵袭伪足与前缘板伪足中的作用所做的观察可以扩展到三维侵袭,其中基质降解和散装机车突起隔室会聚到同一空间。 我们将使用我们的新的基因编码的Rac 1 GTdR的生物传感器来解决这个问题,能够在亚细胞分辨率下真实的时间内报告Rac 1的激活动力学,我们将利用最先进的Rac 1 GTdR的光释放技术来进一步解决Rac 1激活在侵袭伪足中的作用。 这项研究将提供第一个证据,证明单个GTCRac 1的激活循环如何能够在2D和3D侵袭环境中有效地将侵袭/运动机制的表型从基质降解转换为大量运动突起。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Louis Hodgson其他文献

Louis Hodgson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Louis Hodgson', 18)}}的其他基金

Multiplex Imaging of Signaling Pathways in Cell Motility
细胞运动信号通路的多重成像
  • 批准号:
    10457496
  • 财政年份:
    2020
  • 资助金额:
    $ 17万
  • 项目类别:
Multiplex Imaging of Signaling Pathways in Cell Motility
细胞运动信号通路的多重成像
  • 批准号:
    10681274
  • 财政年份:
    2020
  • 资助金额:
    $ 17万
  • 项目类别:
Multiplex Imaging of Signaling Pathways in Cell Motility
细胞运动信号通路的多重成像
  • 批准号:
    10224266
  • 财政年份:
    2020
  • 资助金额:
    $ 17万
  • 项目类别:
Multiplex Imaging of Signaling Pathways in Cell Motility
细胞运动信号通路的多重成像
  • 批准号:
    10471441
  • 财政年份:
    2020
  • 资助金额:
    $ 17万
  • 项目类别:
Multiplex Imaging of Signaling Pathways in Cell Motility
细胞运动信号通路的多重成像
  • 批准号:
    10581027
  • 财政年份:
    2020
  • 资助金额:
    $ 17万
  • 项目类别:
Roles of formins in breast cancer invasion
福尔明在乳腺癌侵袭中的作用
  • 批准号:
    9254499
  • 财政年份:
    2016
  • 资助金额:
    $ 17万
  • 项目类别:
Roles of formins in breast cancer invasion
福尔明在乳腺癌侵袭中的作用
  • 批准号:
    9098870
  • 财政年份:
    2016
  • 资助金额:
    $ 17万
  • 项目类别:
Rac1 regulates protrusion and invasion of breast cancers in 3D
Rac1 以 3D 方式调节乳腺癌的突出和侵袭
  • 批准号:
    8751217
  • 财政年份:
    2014
  • 资助金额:
    $ 17万
  • 项目类别:
Rac1 regulates protrusion and invasion of breast cancers in 3D
Rac1 以 3D 方式调节乳腺癌的突出和侵袭
  • 批准号:
    8878203
  • 财政年份:
    2014
  • 资助金额:
    $ 17万
  • 项目类别:
RhoC GTPase regulates leading edge protrusion dynamics in breast carcinomas
RhoC GTPase 调节乳腺癌前缘突起动力学
  • 批准号:
    7861954
  • 财政年份:
    2010
  • 资助金额:
    $ 17万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 17万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 17万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 17万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 17万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 17万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 17万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了